MedTrace Logo

Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550

NCT00414661 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 162

Last updated 2013-01-01

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to follow the health of subjects who have previously been enrolled in studies of CP-690,550 for treatment of their rheumatoid arthritis. Subjects are only eligible for this study after they have completed all participation in other studies of CP-690,550.

Conditions

  • Arthritis, Rheumatoid

Interventions

DRUG

CP-690,550

Subjects had to have received CP-690,550 or other blinded study drug in index study. No intervention in this long-term follow-up trial.

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • United States
  • Argentina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • Czechia
  • Dominican Republic
  • Finland
  • Greece
  • Hungary
  • India
  • Italy
  • Japan
  • Mexico
  • Poland
  • Puerto Rico
  • Slovakia
  • South Korea
  • Spain
  • Ukraine

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00414661 on ClinicalTrials.gov